Federal Policy
Latham & Watkins Publishes July 2026 Drug Pricing Digest
Latham & Watkins LLP released its July 2026 Drug Pricing Digest, a recurring compilation tracking developments in the Medicaid Drug Rebate Program, 340B Program, Medicare drug pricing policy, and state pharmaceutical law. The digest appears to be a monthly or periodic roundup of regulatory and legislative activity affecting prescription drug pricing and market access. No specific policy changes or rulemakings are described in the brief excerpt provided. The digest serves as a reference tool for stakeholders monitoring evolving drug pricing regulations across federal programs including Medicaid.
Why it mattersThis digest compiles recent Medicaid Drug Rebate Program activity that may affect MCO pharmacy benefit management, supplemental rebate negotiations, and compliance with evolving federal and state drug pricing requirements.
Also covered by:jdsupra.com